COMPOSITION FOR DIAGNOSIS OF AMYLOID-RELATED DISEASE
申请人:Nakayama Morio
公开号:US20100278733A1
公开(公告)日:2010-11-04
There is provided a composition comprising a compound represented by general formula (I), wherein R
l
represents a 5-iodothiophen-2-yl group or the like, and R
2
represents a 4-dimethylaminophenyl group or the like. This composition is useful for diagnosis of an amyloid-related disease such as Alzheimer's disease because the compound has high binding specificity to amyloid β protein, high permeability through the blood-brain barrier, and a property of being rapidly eliminated from sites other than senile plaques in the brain.
COMPOSITION FOR DIAGNOSING AMYLOID-RELATED DISEASE
申请人:Nagasaki University
公开号:EP2030635A1
公开(公告)日:2009-03-04
There is provided a composition comprising a compound represented by general formula (I), wherein R1 represents a 5-iodothiophen-2-yl group or the like, and R2 represents a 4-dimethylaminophenyl group or the like. This composition is useful for diagnosis of an amyloid-related disease such as Alzheimer's disease because the compound has high binding specificity to amyloid β protein, high permeability through the blood-brain barrier, and a property of being rapidly eliminated from sites other than senile plaques in the brain.